SOPHiA GENETICS (SOPH) Research & Development (2020 - 2025)
SOPHiA GENETICS (SOPH) reported Research & Development of -$8.5 million for Q4 2025, up 6.62% on a YoY basis from -$8.0 million in Q4 2024, and down 5.84% sequentially from -$8.1 million in Q3 2025.
SOPHiA GENETICS (SOPH) Research & Development (2020 - 2025) Analysis & Trends
SOPHiA GENETICS (SOPH) has 6 years of Research & Development data on file, last reported at -$8.5 million in Q4 2025.
- For the quarter ending Q4 2025, Research & Development rose 6.62% year-over-year to -$8.5 million; the trailing twelve-month figure through Dec 2025 stood at -$34.2 million (changed 0.44% YoY), and the FY2025 full-year result was -$34.2 million, changed 0.44% from the prior year.
- Research & Development retreated to -$8.5 million in Q4 2025, from -$8.1 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of -$6.2 million in Q1 2021 to a low of -$10.1 million in Q3 2022.
- A 5-year average of -$8.4 million and a median of -$8.7 million in 2023 frame the typical range for Research & Development.
- Across the five-year window, Research & Development jumped 99.85% in 2021 and tumbled 53.32% in 2022, its largest moves.
- Tracing SOPH's Research & Development over 5 years: stood at -$6.4 million in 2021, then decreased by 6.79% to -$6.8 million in 2022, then sank by 43.73% to -$9.8 million in 2023, then gained by 6.31% to -$9.1 million in 2024, then grew by 6.62% to -$8.5 million in 2025.
- Business Quant data shows SOPH's Research & Development at -$8.5 million in Q4 2025, -$8.1 million in Q3 2025, and -$8.5 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 29.34 Bn | 22.03 Bn | 662.02 Mn | 208.32 Mn |
| 2 | BrightSpring Health Services | 13.49 Bn | 12.59 Bn | 482.22 Mn | - |
| 3 | Healthequity | 7.96 Bn | 7.70 Bn | 256.31 Mn | 26.83 Mn |
| 4 | 10x Genomics | 6.17 Bn | 5.63 Bn | 106.18 Mn | 56.85 Mn |
| 5 | Hinge Health | 6.02 Bn | 5.70 Bn | 154.23 Mn | 30.34 Mn |
| 6 | MiniMed | 4.19 Bn | 3.89 Bn | 480.00 Mn | 99.00 Mn |
| 7 | Waystar Holding | 4.14 Bn | 4.07 Bn | 216.84 Mn | 45.83 Mn |
| 8 | Doximity | 3.82 Bn | 3.08 Bn | 125.97 Mn | 39.11 Mn |
| 9 | Privia Health | 3.10 Bn | 2.73 Bn | - | 8.13 Mn |
| 10 | SOPHiA GENETICS | 408.62 Mn | 338.33 Mn | 14.69 Mn | -8.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -8.54 Mn |
| Sep 30, 2025 | -8.07 Mn |
| Jun 30, 2025 | -8.49 Mn |
| Mar 31, 2025 | -9.12 Mn |
| Dec 31, 2024 | -9.14 Mn |
| Sep 30, 2024 | -7.87 Mn |
| Jun 30, 2024 | -7.96 Mn |
| Mar 31, 2024 | -9.39 Mn |
| Dec 31, 2023 | -9.76 Mn |
| Sep 30, 2023 | -8.98 Mn |
| Jun 30, 2023 | -8.89 Mn |
| Mar 31, 2023 | -9.33 Mn |
| Dec 31, 2022 | -6.79 Mn |
| Sep 30, 2022 | -10.12 Mn |
| Jun 30, 2022 | -8.99 Mn |
| Mar 31, 2022 | -9.48 Mn |
| Dec 31, 2021 | -6.36 Mn |
| Sep 30, 2021 | -7.66 Mn |
| Jun 30, 2021 | -6.39 Mn |
| Mar 31, 2021 | -6.18 Mn |